Close
  Indian J Med Microbiol
 

Figure 2: Computed Tomography (CT) and positron-emission tomography (PET) of liver metastasis and bone metastasis. (a-c), CT before Doc/Bev therapy, (d-f), CT before gemcitabine/cisplatin regimen re-challenge; (g-i,) CT before pembrolizumab treatment; (j-n,) CT after pembrolizumab; (o-p), PET after pembrolizumab; (q), PET after pembrolizumab

Figure 2: Computed Tomography (CT) and positron-emission tomography (PET) of liver metastasis and bone metastasis. (a-c), CT before Doc/Bev therapy, (d-f), CT before gemcitabine/cisplatin regimen re-challenge; (g-i,) CT before pembrolizumab treatment; (j-n,) CT after pembrolizumab; (o-p), PET after pembrolizumab; (q), PET after pembrolizumab